732-918-0207

News & Publications

QualTech Laboratories is proud to remain on the cutting edge of the pharmaceutical industry. Our biological and heparin studies, anti-factor Xa activity testing, anti-factor IIa assays, and quality control procedures remain unequaled in the U.S., as demonstrated in the following news items and trade publications.

QualTech – The #1 Analytical Testing Laboratory in the U.S. Specializing in:
Biological Assays · Heparin Studies · Toxicity Studies
Anti-Factor Xa Activity Testing · Anti-Factor IIa Assays



August 12, 2009
QualTech Laboratories Validates USP Protocols for Anti-Factor IIa Chromogenic Assay for Potency

QualTech Responds Proactively to New Heparin Sodium Monograph Requirements

OCEAN, NJ, August 12, 2009 -- QualTech Laboratories, Inc., an analytical testing laboratory specializing in biological assays, toxicity studies, and quality control measures, announced today that they have validated the USP (United States Pharmacopeia) method for the anti-factor IIa chromogenic assay for potency. This anti-factor IIa assay is a required component of the newly-revised Heparin Sodium monograph, which becomes effective October 1, 2009.

Read more
November 09, 2005
Mixed protocols: Multiple ratios of FSH and LH bioactivity using highly purified, human-derived FSH

Mixed protocols: Multiple ratios of FSH and LH bioactivity using highly purified, human-derived FSH (BRAVELLE) and highly purified hMG (MENOPUR) are unaltered by mixing together in the same syringe

M Joseph Scobey,corresponding author - Elizabeth Raike - and Dennis C Marshall

This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Read more

QualTech Laboratories, Inc.  |  104 Green Grove Road, Ocean, NJ 07712  |  Phone: 732-918-0207 Design by Ginger Graphics